Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 4 Advanced Cancer 3 Uveal Melanoma 2 Recurrence 2 Lymphoma, Non-Hodgkin 2 Various Advanced Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Microsatellite Unstable Colorectal Cancer 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Advanced Gastric Cancer 1

Interventions

Nivolumab 5 Ipilimumab 3 relatlimab 1 daratumumab 1 Fluorouracil 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Various Advanced Cancer × relatlimab × Clear all

NCT02488759 2023-11-13

CheckMate358

Bristol-Myers Squibb

Phase 1/2 Completed

578 enrolled 19 charts

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡